LivaNova Presents New Data at European Association for Cardio-Thoracic Surgery Annual Meeting Demonstrating Benefits of Perceval Sutureless Valve
LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced new data from the Perceval® Sutureless Implant Versus Standard-Aortic Valve Replacement (PERSIST-AVR) clinical study and the Sorin Universal Registry on Aortic Valve Replacement (SURE-AVR). Results from a PERSIST-AVR sub-analysis demonstrated better clinical outcomes for patients with aortic valve stenosis who received the Perceval sutureless surgical aortic valve via minimally invasive cardiac surgery (MICS) than patients who received a stented valve through the same access. Data from a SURE-AVR sub-analysis further supported positive findings for Perceval using MICS or full sternotomy. The results were presented during a series of presentations at the 34th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).
“The new PERSIST-AVR data presented at EACTS highlight that the Perceval valve is a reliable and essential technology to be considered as part of any comprehensive valve program and an essential complement to transcatheter technology. Due to its innovative sutureless design, Perceval facilitates minimally invasive cardiac surgery and offers these patients significant benefits such as decreased procedure times, fewer complications and fewer re-hospitalizations,” said Dr. Brian Duncan, Vice President of Medical Affairs at LivaNova. “New findings from SURE-AVR presented at EACTS further demonstrate important benefits from innovation in our next-generation Perceval Plus valve resulting in improved patient outcomes.”
PERSIST-AVR Clinical Study
The prospective, randomized, multi-center, international PERSIST-AVR study assessed the safety, efficacy and noninferiority of the sutureless Perceval valve compared with standard stented bio-prostheses using conventional or mini-sternotomy. A total of 910 patients with severe symptomatic aortic valve stenosis were enrolled in 12 countries. A total of 578 patients underwent isolated aortic valve replacement (AVR).
PERSIST-AVR results presented during EACTS showed that patients who received Perceval during a mini-sternotomy in isolated AVR had a significantly lower incidence of:
- Major adverse cardiovascular and cerebrovascular events (MACCEs) – 5.2% of the Perceval group versus 10.8% of the stented valve group
- New onset of atrial fibrillation – 4.2% in the Perceval group versus 11.4% in the stented valve group
- Stroke – 1% in the Perceval group versus 5.4% in the stented valve group
Prof. Roberto Lorusso, Full Professor in the Cardio-Thoracic Surgery Department of the Maastricht University Medical Centre, the Netherlands, presented the new PERSIST-AVR data. “In this sub-cohort, Perceval significantly reduced MACCEs at one-year follow up, reduced re-hospitalization days and demonstrated a 30% reduction in cross-clamping time, providing patients with a minimally invasive and less traumatic surgical solution compared to stented valves,” said Prof. Lorusso. “This data is encouraging as it provides further evidence that Perceval facilitates MICS and simplifies complex procedures when time matters.”
The ongoing, prospective, international SURE-AVR registry used real-world data to compare outcomes of patients who received Perceval using MICS or conventional full sternotomy. SURE-AVR is collecting data on outcomes from patients at 60 sites in 18 countries. One sub-analysis presented at EACTS was based on data from 980 isolated AVR patients at 52 international institutions. A total of 676 patients underwent MICS and 304 received a full sternotomy. Results showed that Perceval enables MICS, providing a rate of successful implantation similar to that of full sternotomy.
Dr. Marco Solinas, Cardiac Surgeon, G. Monasterio Foundation Heart Hospital, Massa, Italy, presented the SURE-AVR registry data at EACTS. “These real-life results from an international registry showed that implanting Perceval during MICS resulted in significantly shorter ICU stays than a complete sternotomy and that Perceval in isolated AVR is associated with early- and mid-term good clinical and hemodynamic results both in MICS and full sternotomy,” said Dr. Solinas. “Furthermore, Perceval in MICS results in comparable cross-clamping time to full-sternotomy, eliminating the main concern for broader MICS adoption and reinforcing the role of Perceval as a MICS enabler.”
Analysis of the SURE-AVR registry also provided initial real-world clinical performance data of the Perceval Plus™ valve. Perceval Plus is designed to enhance the Perceval platform by decreasing permanent pacemaker implantation (PPI) rates and improving durability, further advancing the treatment of aortic valve stenosis. Of patients enrolled in SURE-AVR between March 2011 and February 2020, 1,374 underwent AVR with the Perceval valve and 121 with the Perceval Plus valve.
PD Dr. Maximilian Scherner, Department of Cardiac and Thoracic Surgery, University Hospital Magdeburg, Germany, presented data from SURE-AVR related to Perceval Plus during EACTS. “Perceval Plus further improved patient outcomes with reduced pacemaker implantation rates compared to Perceval, while both valves were associated with overall low morbidity and mortality,” said PD Dr. Scherner. “Changes to the design did not impact the sealing at the annulus, and both Perceval and Perceval Plus demonstrated a low percentage of paravalvular regurgitation.”
LivaNova received CE Mark for Perceval in 2011 followed by U.S. Food and Drug Administration approval in 2016. The company received CE Mark for Perceval Plus in 2018. To date, more than 50,000 patients worldwide have been treated with the Perceval valve. To learn more about Perceval and Perceval Plus, visit www.livanova.com.
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. LivaNova operates as two businesses: Cardiovascular and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston (U.S.), respectively.
For more information, please visit www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements” concerning our goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding Perceval, Perceval Plus and findings from the PERSIST-AVR clinical study and SURE-AVR registry. Actual results may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented by any risk factors contained in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. We undertake no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
LivaNova PLC Media Contact
Deanna Wilke, +1 (281) 727-2764
VP, Corporate Communications
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ergomotion Announces Opening of First Manufacturing Facility in North America29.10.2020 22:28:00 CET | Press release
Ergomotion, part of the Keeson Technology Group and the largest manufacturer of adjustable bases worldwide, will open a 250,000 square foot manufacturing facility in Ciudad Juárez, Chihuahua, the company’s first assembly plant in North America. The expansion was fueled by the decision to increase product capabilities, oversee manufacturing functions, and ultimately to stay closer to Ergomotion’s customer base in the United States. “We see a prime opportunity with the North America expansion to enhance the customer service experience in the U.S.,” says Johnny Griggs, Chief Operating Officer at Ergomotion. “Our goal is to provide our partners with world class manufacturing and supply chain and to help grow and strengthen their business. We’re excited to partner with Ciudad Juárez to expand our manufacturing capabilities and make this project viable and successful.” Ergomotion is making a significant investment that will allow for the creation of 400 jobs, within the local economy. The Ju
IDEMIA Launches Converged Card to Enable Financial Inclusion with Identity and Payment Card Solution29.10.2020 17:45:00 CET | Press release
IDEMIA, a global leader in identity and security solutions and the number one provider of driver’s licenses in the U.S., today announced the development of a Converged Card solution in partnership with Mastercard, allowing cardholders to safely and securely shop for everyday essentials. The solution will help bring more people into the formal economy in the U.S. who currently have limited or no access to financial services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029005916/en/ IDEMIA Launches Converged Card to Enable Financial Inclusion with Identity and Payment Card Solution (Photo: Business Wire) Converged Card1 is a state-issued driver’s license or identification with a payment credential. This card or digital application will support state-subsidized programs, including unemployment benefits, housing and utility assistance, and tax refunds, allowing the government to automatically reach people that need funding
Airship Named a Leader in the 2020 Gartner Magic Quadrant for Mobile Marketing Platforms29.10.2020 16:34:00 CET | Press release
Customer engagement companyAirship today announced that it has been named a Leader by Gartner, Inc. in its 2020 Magic Quadrant for Mobile Marketing Platforms.1 Among 13 vendors evaluated, Airship was positioned highest in its ability to execute and furthest to the right for its completeness of vision for the second consecutive year. A complimentary copy of the report is available from Airship. “Airship’s long held global leadership in customer engagement is experiencing dramatic acceleration, as new mobile-first capabilities like Airship Journeys make it much simpler and more effective to grow customer lifetime value in the omnichannel era. I believe Airship’s latest innovations, as well as expansions to experimentation and commerce, are already recognized as major beneficial differentiators in comprehensive evaluations like Gartner’s Magic Quadrant and Critical Capabilities reports,” said Brett Caine, CEO and president, Airship. “As mobile becomes increasingly vital for brands and the
myPOS Turns Smartphones Into POS Terminals29.10.2020 16:02:00 CET | Press release
Business professionals can now take card payments directly on their Android phone with the new Soft POS solution myPOS Glass by the European fintech provider myPOS (www.mypos.com). The innovative mobile app enables payments with contactless cards and smart accessories directly on a mobile Android phone. The accepted payments are deposited immediately in the merchant's free e-money account thanks to the instant settlement feature that myPOS offers at no extra cost for its clients. The Soft POS solution can be used on Android devices that have an NFC (Near Field Communication) chip, which is present in most current smartphones. It does not require additional hardware or cables to turn the phone into a payment terminal. myPOS Glass accepts all types of credit, debit and prepaid Mastercard and Visa cards, as well as wallets like Apple Pay, Google Pay and Samsung Pay. The application meets all industry standards for data protection and security. It ensures that the cardholder's data is not
Andersen Global Extends Coverage in St. Kitts and Nevis29.10.2020 14:30:00 CET | Press release
Andersen Global continues its Caribbean expansion through a Collaboration Agreement with full-service accounting firm Lanns-Monish & Associates, adding dimension to the organization’s presence in St. Kitts and Nevis. Founded in 1991, the Basseterre-based firm is led by founder and Office Managing Director Marcella Lanns-Monish. The team of ten professionals provides tax and accounting services to domestic and international clients, including business advisory, corporate restructuring, tax compliance, payroll and risk advisory. In addition, they provide services to a variety of industries, including hospitality, tourism, manufacturing and the public sector. “The dedication and stewardship of our team to provide clients with best-in-class service has helped us become leaders in our practice areas,” said Marcella. “This collaboration will allow us to take our client service to the next level and expand our reach more broadly. We are excited to work in tandem with Andersen’s collaborating
Conviva’s Latest Streaming Data Shows Advertisers Beginning to Reemerge; Rise of Smart TVs Slows Growth for Connected TV Devices29.10.2020 14:00:00 CET | Press release
Conviva, the leader in global streaming media intelligence, released its quarterly State of Streaming report for Q3 2020 today, showing a 57% year over year increase in overall viewing time, continuing the trend of multiple quarters of strong streaming growth. The report also uncovered new streaming trends including the long-awaited return of advertisers and the increasing battle between smart TVs and connected TV devices such as Roku. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029005174/en/ Conviva's State of Streaming - Q3 2020 (Graphic: Business Wire) “Streaming has exploded in the past year as illustrated by content like the NFL which saw 41% growth on streaming and remained relatively flat on linear TV,” said Bill Demas, CEO, Conviva. “As a result, we are seeing more investment in streaming services, advertisers shifting to streaming platforms and consumers adopting streaming-enabled devices and TVs at a rapid pa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom